Fig. 3From: Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinomaApplication of cfDNA/ctDNA (Icons made by Flaticon, www.flaticon.com). cfDNA can be used to quantified levels and depict cancer genomic landscapeBack to article page